RESPONSIBILITIES:* Unique Hospital product (Drug/Device) for the management of progressive Parkinson's Disease requiring advanced account management abilities and multiple hospital key stakeholder management* Coaching, development and retention of 5 Account Managers nationally: - Account Management - Key stakeholder engagement - Patient-Centric selling skills - barriers to product and patient care access, hospital sector/business mutually beneficial outcomes and solutions - Hospital Formulary processes and documentation - Hospital New Intervention (Device) Advisory Committee processes and documentation* Recruitment and Interviewing* Performance Reviews and management* Internal relationship management eg MSLs, Medical Managers etc* Mentoring new National Sales Managers and leadership within NSM peer groupACHIEVEMENTS:* 2017 Perf to Target - 100%* 2018 Perf to Target - 108%* 2019 Perf to Target - 98%* 2020 Perf to Target - 100% (COVID-19 impacted revision)* 2021 Perf to Target - 101% (COVID-19 impacted revision)* High Team (Direct Reports) Engagement score - 96% v 82% total company* High People Leader Dimensions score - 92% v 84% total company

RESPONSIBILITIES:* Interventional cardiology and peripheral vascular device sales* Delivering on quarterly territory sales target* Sales data analysis and the development of business plans to maximise territory sales* Uncovering and understanding clinician needs and desired patient outcomes and matching Cordis products to identified needs* Device training and cath lab support of cardiologists and vascular surgeons* Account Management -consignment stock/inventory management, invoices, purchase orders, supply and backorder issues and associated relationships (eg supply staff, finance staff)* Product education training for Cath Lab theatre staff* Hospital contracts, tendering and new product introductionsACHIEVEMENTS:* Exceeded Perf to Target Q3 2016 (109%)* Exceeded Perf to Target Q4 2016 (102%)

The HSDM role sits within the Health Care Solutions Business Unit. The BU was newly formed in 2013 to explore opportunities to innovate and partner with health service providers in order to improve the delivery of services to patients and their health outcomes.RESPONSIBILITIES:* Retain business or secure incremental access for current brands through the removal or resolution of non-clinical barriers to prescribing* Via key customer insights, uncover innovative value propositions that demonstrate mutually beneficial, joint-working initiatives with Janssen customers* Adopt a leadership role with in-field health care solutions (HCS) assisting with the development, implementation and refinement of solutions/programs (testing concepts and prototypes). Secure Executive level support for the solutions and facilitate positive environments for implementation and patient pull through. * Develop and present business cases to support the development of health care solutions programs* Champion the company, therapeutic area or brand level value proposition(s) enhancing the company's reputation and ensuring the company is positioned as a preferred partner and trusted adviser with key stakeholders.* Provide local market insights, data and benchmarking to support informed decision-making and opportunity identification* Understand and communicate the national, state and hospital policy agenda, funding flows and competitor landscape in key therapeutic areasKEY ACHIEVEMENTS:* Retained sales of at-risk account valued at $500k (2014)* Project Lead, Schizophrenia Clinical Guidelines app (2014)* Identified opportunity and implemented ATLAS program (supporting mental health patients transition to primary care) - 2014/15* Chemotherapy at Home opportunity analysis (2015)

RESPONSIBILITIES:* Company-wide strategic management of Janssen Retail and Hospital Key Accounts within Queensland (financial and commercial relationships)* Negotiating timely access to new Janssen medicines within the Qld health sector; lead Qld Health (QH) 'List of Approved Medicines' (LAM) submissions and strategy* Lifecycle Management of Janssen brands within Qld including off-patent brand retention via strategic leadership of Queensland Health tenders and the negotiation of commercial agreements with public and private Hospitals, third party pharmacy providers and Qld-based retail pharmacy buying groups* Identifying/developing new commercial growth strategies for existing brands* Manage the company's relationships with QH Purchasing and Logistics, third party pharmacy providers and retail pharmacy buying groups.* Track performance of commercial agreements against terms and conditions and resolve identified commercial issues* Developed and presented market intelligence and health policy reports for Janssen's Board of Management * National Key Account project workKEY ACHIEVEMENTS:* Achieved Janssen’s fastest, successful ‘List of Approved Medicines’ (LAM) submission for a S85 medicine (2012)* As part of above submission, negotiated 'first-of-it's-kind' Product Pricing Arrangement (2012)* Negotiated, established commercial terms/signed and performance tracked agreements for a variety of off-patent molecules exceeding targets set (2011-2012)* Global Leadership Award - Sublimaze strategy (2010)* Established QH KPI wholesaler benchmarking project (2012)* Built Janssen's automated Key Account Sales Analysis Tool (2011)* Medallion Club nominee (Manager of the Year) - 2011

KEY ACHIEVEMENTS:* Medallion Club Winner (Sales Manager of the Year) - 2008* Medallion Club nominee (Sales Manager of the Year) - 2009

KEY ACHIEVEMENTS:* Led No 1 ranked GP sales team nationally (of 8 teams) for: - Pariet/Risperdal combined (2005) - Risperdal (2004) - OTC products sales (2004)

KEY ACHIEVEMENTS:* Medallion Club winner (Sales Representative of the Year) - 2000